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The PRaCTICaL study of nurse led, intensive care follow-up
programmes for improving long term outcomes from critical
illness: a pragmatic randomised controlled trial
B H Cuthbertson, chief of critical care medicine and professor of anaesthesia,1 J Rattray, senior lecturer,2 M K
Campbell, director and professor,3 M Gager, intensive care follow-up nurse,4 S Roughton, intensive care
follow-up nurse,3,5 A Smith, intensive care follow-up nurse,2 A Hull, consultant pyschiatrist,6 S Breeman, trial
manager,3 J Norrie, professor of biomedical statistics,7 D Jenkinson, statistician,3 R Herna´ndez, health
psychologist,3,8 M Johnston, professor of health psychology,9 E Wilson, consultant in anaesthesia and
intensive care ,10 C Waldmann, consultant in anaesthesia and intensive care4 on behalf of the PRaCTICaL
study group
ABSTRACT
Objectives To test the hypothesis that nurse led follow-up
programmes are effective and cost effective in improving
quality of life after discharge from intensive care.
Design A pragmatic, non-blinded, multicentre,
randomised controlled trial.
Setting Three UK hospitals (two teaching hospitals and
one district general hospital).
Participants 286 patients aged ≥18 years were recruited
after discharge from intensive care between September
2006 and October 2007.
Intervention Nurse led intensive care follow-up
programmes versus standard care.
Main outcome measure(s) Health related quality of life
(measured with the SF-36 questionnaire) at 12 months
after randomisation. A cost effectiveness analysis was
also performed.
Results 286 patients were recruited and 192 completed
one year follow-up. At 12 months, there was no evidence
of a difference in the SF-36 physical component score
(mean 42.0 (SD 10.6) v 40.8 (SD 11.9), effect size 1.1
(95% CI −1.9 to 4.2), P=0.46) or the SF-36 mental
component score (effect size 0.4 (−3.0 to 3.7), P=0.83).
There were no statistically significant differences in
secondary outcomes or subgroup analyses. Follow-up
programmes were significantly more costly than standard
care and are unlikely to be considered cost effective.
Conclusions A nurse led intensive care follow-up
programme showed no evidence of being effective or cost
effective in improving patients’ quality of life in the year
after discharge from intensive care. Further work should
focus on the roles of early physical rehabilitation,
delirium, cognitive dysfunction, and relatives in recovery
from critical illness. Intensive care units should review
their follow-up programmes in light of these results.
Trial registration ISRCTN 24294750
INTRODUCTION
More than 140 000 patients are admitted to intensive
care units in the United Kingdom each year, of whom
more than 50 000 die within a year of admission.1 2
These patients have an excess long term risk of death
comparedwith the general populationmatched for age
and sex,3 4 and a substantial percentage continue to
experience both physical and psychological problems
after discharge.5-11 Studies assessing health related
quality of life after intensive care suggest that it
improves over time but that people do not return to
the same level of health that they had before they fell
ill and their health related quality of life is lower than
the general population norms for at least the first
year.1 2 12-18 The reported prevalence of anxiety,
depression, and post-traumatic stress disorder is also
high and may endure for many years.7 8 10 17 18 Patients’
perceptions of their intensive care experience are also
associatedwith subsequent distress.19-22 These continu-
ing problems have implications for patients and
families and carers, and impose a continuing financial
burden on primary and secondary health services.
A follow-up programme after intensive care has
been suggested as a potential means of addressing
these issues, but there is little evidence to suggest that
such an intervention is effective. Despite this lack of
evidence, at least 80 hospitals across the UK have
now developed such follow-up services in an attempt
to improve outcomes after discharge.23 Despite UK
guidelines, the nature of these programmes varies
markedly between centres, and no optimal model has
been identified.23 24Given thewidespread proliferation
of these programmes, it is crucial that their effective-
ness is established without delay. We formally tested
the hypothesis that nurse led follow-up programmes
are effective at improving physical and psychological
health related quality of life in the year after discharge
from intensive care.
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METHODS
Participants and treatment allocation
Patients were recruited from three UK hospitals (two
teaching hospitals and one district general hospital)
from September 2006 until October 2007. All patients
receiving level 3 dependency (intensive care unit) care
at any time during their hospital stay andwho survived
until hospital discharge were eligible for inclusion in
the trial.24 Patients less than 18 years old, not expected
to survive to leave hospital, unable to complete ques-
tionnaires or attend clinics, and who did not consent to
participate were excluded. Patients were approached
in the period after discharge from intensive care
when they were able to give informed consent. Before
the participants’ randomisation, we recorded their
baseline measurements, quality of life (with the SF-36
(short form 36) and EuroQol EQ-5D questionnaires),
intensive care experience (ICE score), and mood dis-
order (HADS (hospital anxiety and depression scale)
score).9 25-27 Patients were randomised to intervention
or control in a non-blinded fashion using a compu-
terised telephone randomisation service which incor-
porated minimisation by age, sex, HADS score,
severity of disease (APACHE II (acute physiology,
age, and chronic health evaluation) score), ICE
score,9 and trial centre.
Intervention
Patients randomised to the intervention joined a man-
ual based, self directed, physical rehabilitation pro-
gramme developed by physiotherapists and
introduced by a study nurse. This started in hospital
and continued for three months after discharge.
Patientsmonitored their own compliance and progress
with the manual treatments and were formally
reviewed at nurse led clinics at three months and nine
months after discharge. The timing and format of this
intervention was determined by the results of a survey
of clinical practice conducted by our group, a national
survey, and a national guideline,11 23 24 as well as experi-
ences of intensive care follow-up from one of the trial
centres. The nurses followed a set format with standar-
dised intervention and assessment requirements. An
intensive care consultant was immediately available
for support or to assess the patients for onward referral
to other medical services and on patient request.
Clinic appointments had the following components:
structured case review, discussion of experiences of
intensive care, formal assessment of requirement for
specialist medical referral, and screening for psycholo-
gical morbidity relating to admission to the intensive
care unit (using the Davidson trauma score and
HADS).27 28 Patients with “caseness” or in whom
there was clinical concern were referred for review by
a mental health professional, review of current drug
treatment, visit to the intensive care unit if appropriate,
and physiotherapy if appropriate, and a review letter
on the patient’s progresswas sent to each patient’s gen-
eral practitioner. For more details of the intervention,
see protocol paper.29
All interventions and referrals used standard NHS
pathways. The exception was for psychological ser-
vices, for which we developed assured referral path-
ways owing to the lack of identifiable clinical
pathways for this patient group. The intervention was
rigorously applied in each centre to avoid dependence
on the aptitude of individual nurses. Trial nurses were
trained together by nurses who carried out intensive
care follow-up to ensure standardisation.
The “standard care” group had follow-up in accor-
dance with standard clinical practice with no intensive
care follow-up after hospital discharge. They were fol-
lowed up by their general practitioners and primary
hospital specialty as indicated by these teams.
Outcomes
The primary outcome measures were health related
quality of life (HRQoL) scores at 12 months measured
with the SF-36 questionnaire by means of a postal sur-
vey. Secondary outcomes included HRQoL at six
months, quality adjusted life years (QALYs) at
12 months, incidence and severity of post-traumatic
stress disorder (Davidson trauma score) and anxiety
and depression (using HADS) at six and 12 months,
cost effectiveness at 12months, primary and secondary
healthcare costs in the year after hospital discharge,
andmortality in the 12months after discharge. All out-
comes were measured by postal questionnaire to
Declined
Excluded
(n=111)
(n=386)
Intervention Standard care
Allocated (n=143)
Baseline questionnaire
Responded (n=143)
Allocated (n=143)
Baseline questionnaire
Responded (n=143)
6 month questionnaire
Died
Formal withdrawal
Responded
Not responded at 6 months*
Lost to follow-up
6 month questionnaire
Died
Responded
Not responded at 6 months*
Lost to follow-up
(n=6)
(n=6)
(n=105)
(n=10)
(n=16)
(n=7)
(n=115)
(n=6)
(n=15)
12 month questionnaire
Died
Formal withdrawal
Responded
Lost to follow-up
12 month questionnaire
Died
Formal withdrawal
Responded
Lost to follow-up
(n=18)
(n=11)
(n=92)
(n=22)
(n=14)
(n=2)
(n=100)
(n=27)
Randomised
(n=286)
Patients approached
(n=783)
* Patients who did not complete questionnaire at 6 months but did so at 12 months
Fig 1 | Consort flow diagram of patient recruitment and retention for the study. “Not responded”
relates to patients who did not complete a questionnaire at six months but did so at
12 months (primary outcome point).
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prevent the follow-up becoming a clinical inter-
vention. The researchers handling the outcome sur-
veys were blinded to the intervention group.
Sample size
Previous studies have shown the intensive care patients
had a mean physical component score of the SF-36 of
35 (SD 14) at one year after discharge from intensive
care.2Wepowered the study to detect a effect size of a 5
point increase on the SF-36 physical component score
(about a 0.36 effect size) in the intervention group at
one year. This suggested that 123 patients per group
were required to complete the one year outcome mea-
sure to detect this difference with 80% power and an α
of 0.05. However, the analysis was planned to adjust
for baseline measurement and that the correlation
between baseline, three month, and 12 month SF-36
scores was 0.6 (as had been seen in other studies of
health related quality of life2), implying a sample size
reduction of 36% was feasible. A conservative reduc-
tion of 30% in the estimated sample size could be
achieved without a concomitant loss of power. There-
fore, we required only 86 patients per group to com-
plete the one year outcome measure. Assuming a 20%
loss to follow-up27 9 and a further 20% mortality in the
first year, the total number of patients needed to be
recruited into the study was estimated as 135 per
group.
The primary analyses were based on the principle of
intention to treat. The outcomes were compared
between the groups using analysis of covariance,
adjusting for minimisation factors and the baseline
measurement of the outcome variable (with the excep-
tion of theDavidson trauma score, whichwas notmea-
sured at baseline), with two tailed P<0.05.
Dichotomous outcomes were analysed using logistic
regression. A priori subgroup analyses of the primary
outcome were undertaken for APACHE II severity of
illness, APACHE II comorbidity, intensive care
experience (ICE score), and length of stay in intensive
care, using tests for treatment by subgroup interaction
(two tailed P<0.01).Datawere analysed using SASver-
sion 9.1 software. Sensitivity analyses were also under-
taken around the primary outcomemeasures using the
treatment received and per protocol methods. Patients
were considered to have received the treatment if they
attended at least one of the two clinics. Sensitivity ana-
lysis for loss to follow-upwas performedusingmultiple
imputation methods. Results are presented as effect
sizes and odds ratios where relevant with confidence
intervals.
Economic analysis
Cost per participant for each arm of the trial was calcu-
lated. We estimated use of healthcare resources per
patient bymeans of patient questionnaires andhospital
note reviewover the first year.Unit costs or priceswere
obtained using published estimates30-32 and study-spe-
cific estimates. QALYs were calculated using the area
under the curve method with responses to the EQ-5D
questionnaire valued using UK population tariffs.25
Patients who died were assigned a zero utility weight
from their death to the end of the follow-up. QALYs
before death were calculated using linear extra-
polation. Point estimates for mean costs and mean
QALYs were derived for treatment and standard
groups to obtain incremental cost per QALY gained.
Deterministic and stochastic sensitivity analyses
(based on bootstrapped estimates) addressed different
types of uncertainties within the economic evaluation,
such as the exploration of the effect of those partici-
pants with the greatest costs on the estimates of mean
cost effectiveness.
RESULTS
Baseline characteristics showed that groups were well
balanced in respect of key prognostic variables
(table 1). Fig 1 shows details of patient recruitment
Table 1 | Baseline characteristics of patients recruited after discharge from intensive care to a
nurse led follow-up programme (intervention) or standard care. Values are numbers
(percentages) of patients unless stated otherwise
Intervention (n=143) Standard care (n=143)
Male 86 (60) 86 (60)
Median (IQR) age (years) 59 (46–49) 60 (46–71)
Median (IQR) APACHE II score 19 (15–24) 19 (15–24)
Median (IQR) APACHE II predictive mortality 28.1 (12.3–45.2) 28.5 (12.8–44.9)
APACHE II system failure:
Respiratory 48 (33.6) 42 (29.4)
Cardiovascular 43 (30.1) 42 (29.4)
Neurological 5 (3.5) 11 (7.7)
Gastrointestinal 27 (18.9) 27 (18.9)
Renal 5 (3.5) 3 (2.1)
Metabolic or endocrine 2 (1.4) 2 (1.4)
Haematological 0 1 (0.7)
Trauma 13 (9.1) 15 (10.5)
APACHE II chronic health evaluation 19 (13) 12 (8)
Ventilated during intensive care 139/141 (99)* 139 (97)
Renal replacement therapy during intensive care 19 (13) 13 (9)
Inotropes during intensive care 85 (59) 77 (54)
Median (IQR) length of stay in intensive care (days) 2.9 (1.7–9.5) 3.1 (1.2–7.5)
Median (IQR) time from discharge to randomisation (days) 9.5 (6.7–16.1) 8.6 (4.8–13.3)
Mean (SD) SF-36 score: physical component 33.4 (10.0) 32.6 (9.9)
Mean (SD) SF-36 score: mental component 40.9 (15.2) 41.4 (14.2)
Median (IQR) EQ-5D score 0.52 (0.26–0.73) 0.49 (0.19–0.69)
Median (IQR) HADS: anxiety component 7 (3–10) 7 (4–10)
Median (IQR) HADS: depression component 6 (3–9) 5 (3–9)
Median (IQR) ICE score: awareness 34 (27–38) 34 (28–40)
Median (IQR) ICE score: frightening 17 (12–20) 16 (12–21)
Median (IQR) ICE score: recall 14 (12–17) 15 (12–18)
Median (IQR) ICE score: satisfaction 16 (14–17) 15 (14–17)
Sedative use during intensive care:
Propofol 115 (80) 112 (78)
Morphine 8 (6) 21 (15)
Short acting opiate (fentanyl or remifentanil) 114 (80) 108 (76)
Benzodiazepines 17 (12) 21 (15)
IQR=interquartile range. APACHE=acute physiology, age and chronic health evaluation. SF-36=short form 36. EQ-
5D= EuroQol quality of life measure. HADS=hospital anxiety and depression scale. ICE=intensive care experience
questionnaire.
*Two missing values.
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and retention for the study. In the year after randomi-
sation 18 (13%) of patients in the intervention group
died compared with 14 (10%) of control patients
(odds ratio 1.32 (95% confidence interval 0.59 to
3.01)). Thirteen (4.5%) patients formally withdrew
from the study, and 49 (17.1%) were lost to follow-up.
Table 2 shows the delivery of the intervention in the
treatment group.
No difference between groups was observed in any
of the primary or secondary outcome measures at six
or 12 months (tables 3 and 4). For the SF-36 physical
component, the intervention group had a mean score
of 42 (SD 10.6) compared with 40.8 (11.9) for the stan-
dard group (effect size 1.1 (95% confidence interval
−1.9 to4.2), P=0.46). For SF-36 mental component,
the intervention group had a mean score of 47.1 (SD
12.7) versus 46.8 (12.4) for the standard group (effect
size 0.4 (−3.0 to 3.7), P=0.83). Table 3 presents the
results of the sensitivity analyses for the primary out-
come measure (10 patients in the intervention group
did not attend either of the nurse led clinics and so
were deemed to have not had the intervention): these
showed a slight increase in the observed effect sizes for
the primary outcomes, but they remained non-signifi-
cant. Fig 2 shows the a priori subgroup analyses.
At six and 12 months after discharge from intensive
care, similar percentages of patients in each group had
returned to work (at six months, 40% (16/40) of inter-
vention group v 37% (15/41) of controls, odds ratio
1.16 (95% confidence interval 0.43 to 3.12); at
12 months, 56% (18/32) v 55% (17/31); odds ratio
1.06 (0.35 to 3.21)). Likewise, similar percentages of
patients in each group had seen their general practi-
tioner (at 6 months, 90% (92/102) v 89% (98/110),
odds ratio 1.13 (0.42 to 3.06); at 12 months, 82% (75/
92) v 88% (85/97), odds ratio 0.62 (0.25 to 1.49)). There
were also no significant differences in satisfaction rates
between groups (data not shown). There were no ser-
ious adverse events in either group.
The mean cost of care was £7126 for the intervention
compared with £4810 for standard care (difference
£2316 (95% credible interval −£269 to £4363)). The
mean total QALY was 0.423 in the intervention group
versus 0.426 in the control group (difference −0.003
(−0.065 to 0.060)). The difference in cost was significant
at the 5% level, but the difference in QALYs was not.
Based on the bootstrapped estimates of cost effective-
ness, it is unlikely that follow-upprogrammes after inten-
sive care are cost effective at typical threshold values for
society’s willingness to pay for a QALY. The sensitivity
analysis revealed that the results of the study were not
affected by loss to follow-up.
DISCUSSION
This study is the first randomised controlled trial of a
nurse led follow-up programme over the year after dis-
charge from intensive care. It achieved its target sam-
ple size, and the intervention was reliably delivered.
The outcomemeasures included both general and spe-
cific measures of health related quality of life andmen-
tal health and were appropriate to the research
questions asked. The intervention was not effective in
improving health related quality of life in the year after
discharge from intensive care with regard to the out-
come measures. The intervention also did not show
effectiveness in any of the a priori subgroups, which
included severity of illness, chronic comorbidity,
intensive care experience, and length of stay in inten-
sive care.
We believe that this study has high internal validity.
The study recruited from three centres, one of which
had an existing follow-up service and two that did not.
The expert centre taught the other centres in the deliv-
ery of the intervention. The patients recruited to the
trial are broadly representative of UK intensive care
admissions.1 However, those included in our study
were likely to have beenmore severely ill than patients
admitted to intensive care in other countries as our
patients represented level 3 dependency care or the
requirement for support of multiorgan failure.24 This
may affect the external validity and generalisability of
the result. Study baseline quality of life scores were
Table 2 | Delivery of a nurse led follow-up programme* to 143 patients after discharge
from intensive care. Values are numbers (percentages) of patients unless stated
otherwise
Nurse led clinic
3 months 9 months
No of patients who attended clinic 104 94
Mean (SD) time after randomisation
to clinic appointment (days)
91.3 (19.5) 270 (20.2)
Relative accompanied patient to clinic 46 (44) 31 (33)
Case review 99 (95) 92 (98)
Discussion of intensive care experiences 104 (100) 92 (98)
Assessment of medical referral 94 (90) 83 (88)
Patients referred for specialist review 25 (25) 16 (17)
Total number of specialist referrals: 34 29
Ear, nose, and throat 4 5
Medical or surgical 8 6
Neurology or neurosurgery 0 1
Sexual medicine or urology 1 2
Physiotherapy or occupational therapy 7 6
Dietician 6 1
Speech therapy 2 1
Other 6 7
Psychological screen 103 (99) 93 (99)
Referral for psychological review 25 (24) 6 (6)
Review of current drug therapy 101 (97) 91 (97)
Changes to current medications 3 (3) 2 (2)
Visit to intensive care unit:
Offered 87 (84) 48 (51)
Performed 22 (21) 13 (14)
Physiotherapy or occupational therapy
assessment requested
7 (7) 5 (5)
Intensive care doctor consulted 15 (14) 15 (16)
Intensive care doctor reviewed case 17 (16) 14 (15)
Review letter to patient’s general practitioner 104 (100) 93 (99)
*Patients received a physical rehabilitation handbook from baseline until 3 months, and were reviewed
at nurse led clinics at 3 months and 9 months. Individual patients could have referrals for more than
one treatment.
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measured in hospital after discharge from the intensive
care unit and mean scores for the mental and physical
components of the SF-36 questionnaire were consis-
tent with previous literature.2 33 34 Baseline HADS
scores showed a moderately high overall level of anxi-
ety and depression, as found in previous studies in this
population.
The intervention was delivered with high reliability
in all centres and mirrored UK practice at the time of
development. Markers of this include that more than
90% of patients had the main elements of the inter-
vention delivered. Despite encouragement to do so,
only a minority of patients brought a relative with
them to the clinic.With the key role of relatives in deli-
vering care, we were surprised this number was not
higher. Also, about a third of the patients required spe-
cialist medical referrals and a further third psychologi-
cal referral. These data reflect the high, and
presumably often unmet, need for specialist care in
this patient group. Intensive care doctors were
involved in the care of up to half of the patients at the
clinics, mainly at the request of the nurses rather than
of the patients, andwere involved in all specialist refer-
rals. The vastmajority of patients were offered a visit to
the intensive care unit, and three quarters took up this
offer independently of the clinic appointment. From
these data it is clear that the intervention was coordi-
nated at the clinics but was delivered across the entire
first year after discharge from the intensive care unit.
Losses to the study over the first year were due to
deaths (11.2%), withdrawal, and loss to follow-up
(21.7%). Suchmortality figures are in keepingwith pre-
vious reports from similar patient cohorts.2 34 A 20%
withdrawal or loss to follow-up is also broadly in keep-
ing with other studies in this patient cohort.2 34 How-
ever, we performed sensitivity analysis to analyse the
effects of such losses to follow-up, which showed that
the results were not affected by such losses.
Table 3 | Primary outcome of trial of a nurse led rehabilitation programme for patients discharged from intensive care.
Results were analysed on the basis of intention to treat (adjusted for minimisation covariates*), per protocol, and the
treatment received
SF-36 score at 12 months
Intervention Standard care Effect size
(95% CI) P valueNo of patients Mean(SD)score No of patients Mean(SD)score
Intention to treat analysis
Physical component score 90 42.0 (10.6) 97 40.8 (11.9) 1.1 (−1.9 to 4.2) 0.46
Mental component score 90 47.1 (12.7) 97 46.8 (12.4) 0.4 (−3.0 to 3.7) 0.83
Per protocol analysis
Physical component score 80 42.3 (10.8) 97 40.8 (11.9) 1.6 (−1.6 to 4.8) 0.33
Mental component score 80 48.5 (11.8) 97 46.8 (12.4) 1.7 (−1.7 to 5.1) 0.33
Treatment received analysis
Physical component score 80 42.3 (10.8) 107 40.7 (11.7) 1.7 (−1.4 to 4.8) 0.27
Mental component score 80 48.5 (11.8) 107 45.8 (13.0) 2.6 (−0.8 to 6.0) 0.14
*Minimisation covariates were age, sex, HADS score, APACHE II score, ICE score, and trial centre (see table 1 for definitions of abbreviations).
Table 4 | Secondary outcome measures of trial of a nurse led rehabilitation programme for patients discharged from
intensive care. Results were analysed on the basis of intention to treat (adjusted for minimisation covariates*)
Intervention Standard Effect size
(95% CI) P valueNo of patients Mean(SD)score No of patients Mean(SD)score
SF-36 score at 6 months:
Physical component score 102 39.8 (9.5 110 40.1 (11.7 −0.8 (−3.6 to2.0) 0.59
Mental component score 102 44.7 (14.2 110 45.2 (12.0 −0.6 (−3.9 to2.8) 0.74
EQ-5D quality of life score:
At 6 months 110 0.63 (0.31 121 0.62 (0.3 0.0 (−0.1 to 0.1) 0.83
At 12 months 108 0.58 (0.37 113 0.60 (0.3 −0.0 (−0.1 to0.1) 0.57
Davidson trauma score:
Incidence at 6 months 102 16.1 (15.7 111 19.5 (16.7 −3.6 (−7.6 to0.4) 0.07
Incidence at 12 months 90 13.7 (14.5 99 17.1 (14.7 −3.7 (−7.4 to0.0) 0.05
Severity at 6 months 101 12.3 (14.1 111 15.1 (15.8 −3.1 (−6.7 to0.6) 0.10
Severity at 12 months 89 10.3 (13.9 98 11.9 (13.3 −1.6 (−5.0 to1.9) 0.37
HADS score:
Anxiety at 6 months 105 6.0 (4.5 115 7.0 (4.6 −0.9 (−2.0 to0.1) 0.09
Anxiety at 12 months 92 5.5 (4.6 100 6.4 (4.4 −0.8 (−1.9 to0.4) 0.18
Depression at 6 months 105 5.3 (4.3 115 5.3 (4.0 −0.0 (−1.0 to1.0) 0.99
Depression at 12 months 92 100 −0.1 (−1.2 to1.0) 0.86
*Minimisation covariates were age, sex, HADS score, APACHE II score, ICE score, and trial centre (see table 1 for definitions of abbreviations).
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The scores for the physical and mental components
of the SF-36 rose from baseline values at six and
12 months’ follow-up in both groups but remained
below population norms at all times, in line with pre-
vious findings.218 33 34 Psychological distress scores
tended to improve over the year but still represented
a significant degree of psychological morbidity in both
groups. As above, nearly a third of these patients
required psychological referral, and ready access to
such care is simply not available currently in the UK.
Clearly, despite the results of this study, more needs to
be done to identify patients with significant morbidity
and suitable assessment and treatment options put in
place.
As part of a sensitivity analysis, we analysed the pri-
mary outcomes according to treatment received and
per protocol. These analyses show a slight increase in
the intervention effect, but it remained non-significant.
This may suggest that greater penetration of the inter-
vention contributes to an improved outcome but will
not on its own bring about important improvements.
Subgroup analyses also did not yield any notable dif-
ferences between intervention and control groups.
Akeypart of the economic evaluationwas to explore
under what circumstances the conclusions would alter.
This was undertaken using sensitivity analysis but the
results remained robust to different underlying
assumptions. Furthermore, given that therewas no evi-
dence of differences in QALYs, follow-up pro-
grammes could only be cost effective if they had the
same or lower cost than standard care. This seems
implausible over a 12 month follow-up period given
the data we have. However, for the average difference
in cost of £2316, follow-up programmeswould need to
provide 0.12 QALYs above standard care over a
12 month period to have an incremental cost per
QALY of £20 000. This value is well above the upper
limit of the 95% credible interval obtained in the base
case or any of the sensitivity analyses.
There may be a variety of reasons why an improve-
ment in health related quality of life was not observed
in this study. Firstly, our complex interventionpackage
may truly be ineffective. The intervention was devel-
oped from the experiences of an existing intensive care
follow-up programme with many years experience,
with additional regard to current UK practice in this
field and with detailed knowledge of the morbidity
that occurs in the year after discharge from intensive
care.2 7 9 However, although well informed, these fol-
low-up programmes are not strongly evidence based.
A further reason may be that our intervention did not
account for important aspects of a patient’s illness such
as delirium and cognitive dysfunction and the com-
plexity of the role of patients’ relatives in their recovery
(these aspects have emerged in the literature as impor-
tant factors in patient recovery since our trial inter-
vention was designed).35-37 It may be that medical
review is always appropriate for such complex patients
and that a multiprofessional approach is required for
this group at all times.
Our intervention differed from standard UK prac-
tice in that we included all intensive care patients with
level 3 dependency irrespective of their length of stay
in intensive care. Many centres invite only those
patients with longer lengths of stay to their pro-
grammes, believing that these patients may gain
greater benefit. However, our subgroup analysis did
not show a significant treatment effect in patients with
longer lengths of stay. Further, patients with short stays
are known to have significant physical and psychologi-
cal morbidity after admission to intensive care.
The timing of the interventionmayhave contributed
to the non-significant findings (the first follow-up clinic
was held at threemonths after discharge), and different
results might have been seen if there had been more
emphasis on early interventions occurring in hospital
or in the immediate period after hospital. Our physical
rehabilitation package did, however, start in hospital
but may have been inadequate for the needs of these
patients. A previous study has suggested that a physical
rehabilitation programme does improve physical out-
come when delivered in hospital after discharge from
intensive care through to three months after
discharge.38 The knowledge of physical rehabilitation
requirements after critical illness has advanced since
we designed the intervention, with more attention
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APACHE II score:
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Total > 22
CHE score = 0
CHE score > 0
ICE score:
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Intensive care length of stay:
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> 3 days
≤ 5 days
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SF-36 mental component score
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≤ 3 days
> 3 days
≤ 5 days
> 5 days
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Effect size (95% CI)
CHE = chronic health evaluation
ICE = Intensive care evaluation
Fig 2 | A priori subgroup analyses of SF-36 scores (physical
and mental components) adjusted for minimisation
covariates.
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being paid to starting rehabilitation while the patient is
still in the intensive care unit.39
Elements of our intervention might also have
strayed inadvertently into the practice for our control
patients (that is, contamination across groups might
have occurred). However, the data indicate that there
were higher referral rates to specialist services in the
intervention group than the control group (data not
shown), suggesting that the management of patients
in the intervention group was indeed different from
that in the control group. This gives some reassurance
that contamination was minimal. The intervention
effect was also consistent across the centres, suggesting
there was not differential drift of the components of the
intervention group into the control group across cen-
tres, whichmight have been expected if contamination
had occurred in individual sites.
Finally, the conduct of the study may have inadver-
tently impaired the delivery of the intervention.
Although it is often stated that the conduct of a research
project can improve the studied outcome through the
Hawthorne effect, itmay be that this was not the case in
this study.After the study, the nurseswhodelivered the
intervention indicated that the completion of detailed
questionnaires at the clinic appointments (most of
which were part of the clinical assessment at that time
as well as of the outcomes assessment at the main out-
come points) did sometimes feel intrusive, potentially
making the clinic reviews feel more like a research fol-
low-up session rather than a review and treatment ses-
sion. This may have reduced the effectiveness of the
intervention.
Strengths and limitations of study
Strengths of this study include it being the first multi-
centre randomised controlled trial of nurse led follow-
up of patients over the year after their discharge from
intensive care.We achieved the target sample size, and
the intervention was delivered with high validity. The
outcomes usedwere robust andwell validated in a vari-
ety of clinical areas.Webelieve the studywasdelivered
with high internal reliability. The external validity and
generalisabilitymay be reduced by the high severity of
illness of patients treated inUK intensive care practice.
Limitations include a comparatively small sample size
to detect important changes in less common outcomes,
including some physical and psychological outcomes.
Patient selection may also have been too inclusive for
this study. We selected all patients who had required
intensive care, but the intervention may have been of
greater benefit to more severely ill patients or those
who required longer stay in intensive care.
Future research
Further studies should attempt to identify effective
ways to select patients most likely to benefit from fol-
low-up after intensive care. They also need to elucidate
more clearly the role of delirium and cognitive dys-
function on recovery and indeed on patients’ ability
to complete clinical and outcome questionnaires. A
greater understanding of the complexity of the role of
patients’ relatives in their recovery and rehabilitation
after critical illness is also required. Finally, the role of
early physical rehabilitation based in the intensive care
unit itself needs to be further explored.36
Conclusions
Our study showed no evidence that a nurse led follow-
up programme was effective or cost effective in
improving patients’ health related quality of life in
the first year after their discharge from intensive care.
Hospitals using intensive care follow-up programmes
with a similar model of care should review their prac-
tice in light of our results.
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